The Miami Framework for ALS and related neurodegenerative disorders: an integrated view of phenotype and biology
Michael Benatar(University of Miami), Tahseen Mozaffar(University of North Carolina at Chapel Hill), Terry Heiman‐Patterson(Temple University), Neil Thakur(Amyotrophic Lateral Sclerosis Association), Amelie K. Gubitz, David Benatar(University of Cape Town), Jeremy M. Shefner(Barrow Neurological Institute), Caroline McHutchison(University of Edinburgh), Joanne Wuu(University of Miami), Stanley H. Appel(Houston Methodist), Jalayne J. Arias(University of California, San Francisco), Travis “Pete” Lewis(Eli Lilly (United States)), Volkan Granit(Biohaven Pharmaceuticals (United States)), Adam L. Boxer(University of California, San Francisco), Stephanie Fradette(Biogen (United States)), Ronald B. Postuma(Montreal Neurological Institute and Hospital), Anne‐Laure Grignon(University of Miami), James D. Berry(Clinical Research Institute), Corey T. McMillan(University of Pennsylvania), Ammar Al‐Chalabi(King's College London), Nathan Carberry(University of Miami), Martin R. Turner(University of Oxford), Paul Lingor(German Center for Neurodegenerative Diseases), Penny A. Dacks(Association for Frontotemporal Degeneration), Xueya Cai(University of Rochester), James B. Caress(The University of Texas at San Antonio Health Science Center), Kuldip D. Dave(Amyotrophic Lateral Sclerosis Association), Michael McDermott(Unknown), Jennifer Buczyner(University of Miami), Thomas H. Champney(University of Miami), Bradley F. Boeve(Mayo Clinic in Arizona), Laynie Dratch(University of Pennsylvania), Howard J. Rosen, Edward D. Huey(New York Psychoanalytic Society and Institute), Stephanie Cosentino(Columbia University), Neil A. Shneider(Columbia University Irving Medical Center), Karen A. Lawrence(Eli Lilly (United States)), Henry Houlden(Queen Mary University of London), Peggy Allred(Methodist Hospital), Peter M. Andersen(Umeå University), Oren Levy(Brigham and Women's Hospital), Sharon Hesterlee(Muscular Dystrophy Association), Sharon Abrahams(Mott MacDonald (United Kingdom)), Matthew B. Harms(Columbia University), Meg Bradbury(Novartis (United Kingdom)), Anita Crawley, Lucie Bruijn(Novartis (United Kingdom))
Cited by 40
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k